Drug tied to meningitis reached state, CDC says

10/06/2012 12:00 AM

10/07/2012 12:25 PM

Drug tied to meningitis reached state, CDC says

Four health-care facilities in California received lots of a drug that has been linked to an outbreak of a rare type of meningitis, but none is in the Sacramento region.

The Centers for Disease Control and Prevention on Friday released a list of facilities nationwide that received lots of methylprednisolone acetate from New England Compounding Center in Framingham, Mass., that were recalled last week.

The four California facilities receiving the drug are in Visalia, Encino, Ukiah and Palmdale.

To date, 47 cases of fungal meningitis in seven states have been linked to the injectable steroid medication, and five people have died, according to the CDC.

The majority of the cases, 29, have been reported in Tennessee, with three deaths there. Cases also have been reported in Florida, Indiana, Maryland, Michigan, North Carolina and Virginia.

The patients are thought to have been infected by a fungus that contaminated the steroid drug, which is administered to treat back pain.

Editor's Choice Videos

 

Join the Discussion

The Sacramento Bee is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere on the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Terms of Service